Allermi is a telehealth company that provides personalized prescription allergy relief through custom-formulated nasal sprays. They combine up to four clinically-proven active ingredients into a single spray, tailored to each patient's specific symptoms, with ongoing access to board-certified allergists from top medical institutions.
Custom prescription nasal sprays combining up to 4 active ingredients tailored to individual symptoms, backed by allergists from Stanford, Harvard, and other top institutions, with 90%+ of patients experiencing superior relief compared to previous treatments.
AI Visibility Score
Allermi has an AI visibility score of 33/100, rated as low. This score reflects how often and how prominently Allermi appears in responses from AI assistants like ChatGPT, Claude, and Gemini.
AI Perception Summary
Allermi has successfully established itself as the leading authority for personalized nasal care in Gemini and Claude, yet it remains dangerously invisible during the critical moment when patients realize traditional OTC medications like Flonase and Zyrtec are failing them. While the brand captures the attention of urban professionals, it is currently missing a massive opportunity to dominate the 'Evidence-Based Health Optimizer' segment and the broader ChatGPT ecosystem.
Strengths
- Dominant positioning in Gemini with a 63% mention rate and an impressive average position of 3.4.
- Top-tier rankings (often #1) across Claude, Gemini, and AI Overviews for high-intent queries regarding custom and subscription nasal sprays.
- Strong resonance with the 'Time-Crunched Urban Professional' persona, achieving a 50% mention rate and a positive sentiment profile.
Visibility Gaps
- Severe lack of visibility in ChatGPT, which yielded only a 10% mention rate and poor average positioning.
- Complete absence from 'OTC failure' queries where users specifically mention that standard treatments like Zyrtec are no longer effective.
- Negligible presence for 'Evidence-Based Health Optimizer' personas, who represent the core demographic for medical-grade customization.
- Zero visibility in seasonal preparation queries and kit-building recommendations, leaving the field open to legacy brands like Flonase and Singulair.
Competitors in AI Recommendations
- Flonase: 36 mentions
- Singulair: 27 mentions
- Zyrtec: 26 mentions
- Dymista: 20 mentions
- Astepro: 17 mentions
- Afrin: 17 mentions
- Nasacort: 15 mentions
- Xyzal: 14 mentions
- Claritin: 13 mentions
- Doctor On Demand: 12 mentions
- Wyndly: 11 mentions
- Clarinex: 10 mentions
- Curex: 10 mentions
- Ryaltris: 9 mentions
- Allegra: 9 mentions
Tags: Startups